Ocugen
OCGN
116 hedge funds and large institutions have $396M invested in Ocugen in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 29 reducing their positions, and 30 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 29
36% more call options, than puts
Call options by funds: $46.7M | Put options by funds: $34.4M
0.85% less ownership
Funds ownership: 28.63% → 27.78% (-0.85%)
10% less funds holding
Funds holding: 129 → 116 (-13)
13% less capital invested
Capital invested by funds: $455M → $396M (-$58.4M)
33% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Charles Schwab
San Francisco,
California
|
+$6.49M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.57M |
| 3 |
State Street
Boston,
Massachusetts
|
+$3.39M |
| 4 |
JP Morgan Chase
New York
|
+$3.24M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$17.8M |
| 2 |
Jane Street
New York
|
-$5.8M |
| 3 |
Millennium Management
New York
|
-$3.74M |
| 4 |
Citigroup
New York
|
-$2.49M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.41M |
OCGN Hedge Fund Activity: Q3 2021 in Review
116 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Ocugen (OCGN) for Q3 2021, worth a combined $396M — down 13% from $455M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of OCGN and 20 opened new positions — a net loss of 10 holders — while 29 trimmed existing stakes and 42 added.
The largest buyer was Charles Schwab, adding an estimated $6.49M. The largest seller was Renaissance Technologies, cutting an estimated $17.8M.
- 116 institutional investors held Ocugen (OCGN) as of Q3 2021, down from 129 in Q2 2021.
- Funds reported $396M of Ocugen stock for Q3 2021, down 13% quarter-over-quarter.
- 20 funds opened new Ocugen positions in Q3 2021 and 30 closed out, a net change of -10 holders.
- The largest Ocugen buyer in Q3 2021 was Charles Schwab, an estimated $6.49M added.
- The largest Ocugen seller in Q3 2021 was Renaissance Technologies, an estimated $17.8M sold.
Based on aggregated 13F filings for Q3 2021.